Dias M, Cruz-Cazarim E, Pittella F, Baiao A, Pacheco A, Sarmento B
Drug Deliv Transl Res. 2025; .
PMID: 39751765
DOI: 10.1007/s13346-024-01772-x.
Thomas S, Abhinand K, Menon A, Nair B, Kumar G, Arun K
Int J Mol Sci. 2024; 25(21).
PMID: 39519352
PMC: 11546203.
DOI: 10.3390/ijms252111801.
Sebutsoe X, Tsotetsi N, Jantjies Z, Raphela-Choma P, Choene M, Motadi L
Onco Targets Ther. 2024; 17:785-801.
PMID: 39345275
PMC: 11439348.
DOI: 10.2147/OTT.S475132.
Zhang Y, Tian J
ACS Omega. 2024; 9(36):37459-37504.
PMID: 39281920
PMC: 11391544.
DOI: 10.1021/acsomega.4c04573.
Hussain M, Moglad E, Afzal M, Sharma S, Gupta G, Sivaprasad G
CNS Neurosci Ther. 2024; 30(5):e14763.
PMID: 38790149
PMC: 11126788.
DOI: 10.1111/cns.14763.
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders.
Wal P, Aziz N, Singh C, Rasheed A, Tyagi L, Agrawal A
Curr Gene Ther. 2024; 24(5):356-376.
PMID: 38288826
DOI: 10.2174/0115665232268840231222035423.
Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors.
Lee J, Choi J, Kim E, Choi J, Kim S, Yang Y
ACS Omega. 2023; 8(39):36435-36448.
PMID: 37810687
PMC: 10552107.
DOI: 10.1021/acsomega.3c05395.
The emerging role of MicroRNA-182 in tumorigenesis; a promising therapeutic target.
Sameti P, Tohidast M, Amini M, Bahojb Mahdavi S, Najafi S, Mokhtarzadeh A
Cancer Cell Int. 2023; 23(1):134.
PMID: 37438760
PMC: 10337107.
DOI: 10.1186/s12935-023-02972-0.
Unleash Multifunctional Role of miRNA Biogenesis Gene Variants ( and ) with Susceptibility to Hepatocellular Carcinoma.
Elsalahaty M, Salama A, Diab T, Ghazy M, Toraih E, Elshazli R
J Pers Med. 2023; 13(6).
PMID: 37373948
PMC: 10302587.
DOI: 10.3390/jpm13060959.
MicroRNA-425: A Pivotal Regulator Participating in Tumorigenesis of Human Cancers.
Sameti P, Amini M, Oroojalian F, Baghay Esfandyari Y, Tohidast M, Rahmani S
Mol Biotechnol. 2023; 66(7):1537-1551.
PMID: 37332071
DOI: 10.1007/s12033-023-00756-5.
How molecular techniques are developed from natural systems.
Ronai I
Genetics. 2023; 224(3).
PMID: 37184565
PMC: 10324945.
DOI: 10.1093/genetics/iyad067.
Genetically engineered nanovesicles mobilize synergistic antitumor immunity by ADAR1 silence and PDL1 blockade.
Ding L, Zhang X, Yu P, Peng F, Sun Y, Wu Y
Mol Ther. 2023; 31(8):2489-2506.
PMID: 37087570
PMC: 10422002.
DOI: 10.1016/j.ymthe.2023.04.011.
Structures and Applications of Nucleic Acid-Based Micelles for Cancer Therapy.
Kim H, Kwak M
Int J Mol Sci. 2023; 24(2).
PMID: 36675110
PMC: 9861421.
DOI: 10.3390/ijms24021592.
Biomedical Applications of RNA-Based Devices.
Kim C, Smolke C
Curr Opin Biomed Eng. 2022; 4:106-115.
PMID: 36237555
PMC: 9555388.
DOI: 10.1016/j.cobme.2017.10.005.
Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
Gaeta A, Nourse Jr J, Willicott K, McKay L, Keogh C, Peter K
PLoS Genet. 2022; 18(8):e1010115.
PMID: 35984862
PMC: 9432717.
DOI: 10.1371/journal.pgen.1010115.
Functionalized gold nanostructures: promising gene delivery vehicles in cancer treatment.
Kumar S, Diwan A, Singh P, Gulati S, Choudhary D, Mongia A
RSC Adv. 2022; 9(41):23894-23907.
PMID: 35530631
PMC: 9069781.
DOI: 10.1039/c9ra03608c.
Liposomal siRNA Formulations for the Treatment of Herpes Simplex Virus-1: In Vitro Characterization of Physicochemical Properties and Activity, and In Vivo Biodistribution and Toxicity Studies.
Jbara-Agbaria D, Blondzik S, Burger-Kentischer A, Agbaria M, Nordling-David M, Giterman A
Pharmaceutics. 2022; 14(3).
PMID: 35336008
PMC: 8948811.
DOI: 10.3390/pharmaceutics14030633.
Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm.
Abusalah M, Khalifa M, Al-Hatamleh M, Jarrar M, Mohamud R, Chan Y
J Pers Med. 2022; 12(3).
PMID: 35330388
PMC: 8948998.
DOI: 10.3390/jpm12030386.
Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens.
Mourenza A, Lorente-Torres B, Durante E, Llano-Verdeja J, Aparicio J, Fernandez-Lopez A
Antibiotics (Basel). 2022; 11(3).
PMID: 35326819
PMC: 8944844.
DOI: 10.3390/antibiotics11030356.
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
Zhang Y, Almazi J, Ong H, Johansen M, Ledger S, Traini D
Int J Mol Sci. 2022; 23(5).
PMID: 35269550
PMC: 8909959.
DOI: 10.3390/ijms23052408.